The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies

Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma

(2021) Massa Saab et al.   PLoS One

Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells

(2021) Amina Iftekhar et al.   Nature Communications

A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways

(2020) Mohammed Nabil Quraishi et al.   Journal of Crohns & Colitis

Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

(2020) Cayetano Pleguezuelos-Manzano et al.   NATURE

Role of gut microbiota in type 2 diabetes pathophysiology

(2020) Manoj Gurung et al.   EBioMedicine

Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis

(2020) Ayesha Shah et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis

(2020) Kris V. Kowdley et al.   JOURNAL OF HEPATOLOGY

Colibactin DNA-damage signature indicates mutational impact in colorectal cancer

(2020) Paulina J. Dziubańska-Kusibab et al.   NATURE MEDICINE

Intestinal virome in patients with alcoholic hepatitis

(2020) Lu Jiang et al.   HEPATOLOGY

Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis

(2020) Trevor J. Laborda et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Gut microbiome in primary sclerosing cholangitis: A review

(2020) Rebecca Little et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Oral vancomycin, ursodeoxycholic acid or no therapy for pediatric primary sclerosing cholangitis: a matched analysis

(2020) Mark R. Deneau   HEPATOLOGY

Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis

(2020) Kimberly Hartl et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hepatobiliary acid-base homeostasis: insights from analogous secretory epithelia

(2020) David C. Trampert et al.   JOURNAL OF HEPATOLOGY

Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallbladder Cells

(2020) Ludovico P. Sepe et al.   mBio

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update

(2020) Pufang Tan et al.   Frontiers in Pharmacology

Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis

(2020) Martin Kummen et al.   GASTROENTEROLOGY

UniProt: the universal protein knowledgebase in 2021

(2020) et al.   NUCLEIC ACIDS RESEARCH

Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection

(2019) Christian Lodberg Hvas et al.   GASTROENTEROLOGY

The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC

(2019) Michael Trauner et al.   HEPATOLOGY

Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis

(2019) Nobuhiro Nakamoto et al.   Nature Microbiology

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis

(2019) Jessica R. Allegretti et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation

(2019) Iris C. Steenstraten et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

(2019) Kate D. Lynch et al.   Clinical Gastroenterology and Hepatology

Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

(2019) Sara Lemoinne et al.   GUT

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis

(2019) Malte Rühlemann et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Alterations of the bile microbiome in primary sclerosing cholangitis

(2019) Timur Liwinski et al.   GUT

Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma

(2019) Xiaodong Jia et al.   HEPATOLOGY

Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

(2019) Ayesha Shah et al.   SEMINARS IN LIVER DISEASE

The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile

(2019) Natalia Molinero et al.   Microbiome

Fecal microbiota transplantation beyond Clostridioides difficile infections

(2019) Koen Wortelboer et al.   EBioMedicine

Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review

(2019) Junmin Song et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity

(2019) Michael R. Taylor et al.   Science Advances

Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease

(2019) M. N. Quraishi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

(2019) Zachariah DeFilipp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India

(2019) Ankit Gupta et al.   mSystems

A Mechanistic Insight Into the Role of Gut Microbiota in the Pathogenesis of Primary Sclerosing Cholangitis

(2019) Meha Patel et al.   GASTROENTEROLOGY

Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma

(2018) Brian K. Chung et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon

(2018) Noa Krugliak Cleveland et al.   Clinical Gastroenterology and Hepatology

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features

(2018) Carolina Palmela et al.   Gut and Liver

Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice

(2018) Maria Eugenia Guicciardi et al.   JOURNAL OF HEPATOLOGY

Urbanization and the gut microbiota in health and inflammatory bowel disease

(2018) Tao Zuo et al.   Nature Reviews Gastroenterology & Hepatology

The gut–liver axis and the intersection with the microbiome

(2018) Anupriya Tripathi et al.   Nature Reviews Gastroenterology & Hepatology

Waitlist mortality and post-transplant survival in patients with cholestatic liver disease – Impact of changes in allocation policy

(2018) Katharina Staufer et al.   HPB

Colibactin: More Than a New Bacterial Toxin

(2018) Tiphanie Faïs et al.   Toxins

Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis–ulcerative colitis

(2018) Li-Zsa Tan et al.   GUT

Fecal microbiota transplantation: Review and update

(2018) Jiunn-Wei Wang et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis

(2018) Amandeep K Dhillon et al.   LIVER INTERNATIONAL

Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French–Spanish experience

(2018) Sara Lemoinne et al.   Clinics and Research in Hepatology and Gastroenterology

Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction

(2017) Kristien E. Bouter et al.   GASTROENTEROLOGY

Fungal dysbiosis in cirrhosis

(2017) Jasmohan S Bajaj et al.   GUT

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

(2017) Ruqi Tang et al.   GUT

Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner

(2017) Palak J Trivedi et al.   GUT

Biliary bile acids in hepatobiliary injury – What is the link?

(2017) Peter Fickert et al.   JOURNAL OF HEPATOLOGY

nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

(2017) Peter Fickert et al.   JOURNAL OF HEPATOLOGY

Primary sclerosing cholangitis – a comprehensive review

(2017) Tom H. Karlsen et al.   JOURNAL OF HEPATOLOGY

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

(2017) Subra Kugathasan et al.   LANCET

Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis

(2017) Anna Worthmann et al.   NATURE MEDICINE

The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts

(2017) Johannes Hov et al.   SEMINARS IN LIVER DISEASE

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis

(2017) Lukas Bajer et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia

(2017) Pedro Pereira et al.   PLoS One

The features of mucosa-associated microbiota in primary sclerosing cholangitis

(2016) J. Torres et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection

(2016) Colleen R. Kelly et al.   ANNALS OF INTERNAL MEDICINE

Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma

(2016) F. Avilés-Jiménez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Coevolution between the Human Microbiota and the Epithelial Immune System

(2016) Michael Sigal et al.   DIGESTIVE DISEASES

Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia

(2016) Sonja Boyd et al.   ENDOSCOPY

Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis

(2016) Long-Xian Lv et al.   ENVIRONMENTAL MICROBIOLOGY

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

(2016) Aida Kapic Lunder et al.   GASTROENTEROLOGY

Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis

(2016) Malte Christoph Rühlemann et al.   GUT

The gut-adherent microbiota of PSC–IBD is distinct to that of IBD

(2016) Mohammed Nabil Quraishi et al.   GUT

Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis

(2016) Kentaro Iwasawa et al.   GUT

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

(2016) João Sabino et al.   GUT

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

(2016) Martin Kummen et al.   GUT

Fungal microbiota dysbiosis in IBD

(2016) Harry Sokol et al.   GUT

A triple blinded, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of oral vancomycin in primary sclerosing cholangitis: a pilot study

(2016)   Journal of Gastrointestinal and Liver Diseases

Gut–liver immunity

(2016) Palak J. Trivedi et al.   JOURNAL OF HEPATOLOGY

Signals from the gut microbiota to distant organs in physiology and disease

(2016) Bjoern O Schroeder et al.   NATURE MEDICINE

The role of the gut microbiota in NAFLD

(2016) Christopher Leung et al.   Nature Reviews Gastroenterology & Hepatology

Subversion of host genome integrity by bacterial pathogens

(2016) Cindrilla Chumduri et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Primary Sclerosing Cholangitis

(2016) Konstantinos N. Lazaridis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting Dysbiosis for the Treatment of Liver Disease

(2016) Gobind Anand et al.   SEMINARS IN LIVER DISEASE

Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts

(2016) Fuqiang Ye et al.   PLoS One

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection

(2015) G. Cammarota et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease

(2015) Jason M. Norman et al.   CELL

Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis

(2015) Andreas Wannhoff et al.   Clinical Gastroenterology and Hepatology

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

(2015) James H. Tabibian et al.   HEPATOLOGY

IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism

(2015) Daisaku Yamada et al.   HEPATOLOGY

Parabacteroides faecis sp. nov., isolated from human faeces

(2015) Mitsuo Sakamoto et al.   INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY

Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis

(2015) D. Kevans et al.   Journal of Crohns & Colitis

Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: A pilot study

(2015) Peter De Cruz et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis

(2015) Suguru Mizuno et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis

(2015) Guido Carpino et al.   JOURNAL OF HEPATOLOGY

The Cholangiopathies

(2015) Konstantinos N. Lazaridis et al.   MAYO CLINIC PROCEEDINGS

Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis

(2015) A Boudewijn de Vries   WORLD JOURNAL OF GASTROENTEROLOGY

Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells

(2015) Max Koeppel et al.   Cell Reports

Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria

(2015) Hongzhang Shen et al.   Scientific Reports

Fut2genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis

(2014) C. Rupp et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review with meta-analysis: the relationship between chronicSalmonella typhicarrier status and gall-bladder cancer

(2014) V. Nagaraja et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis

(2014) C. Rupp et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

(2014) Phillip L. Molyneaux et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

(2014) Dirk Gevers et al.   Cell Host & Microbe

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

(2014) Aleksandar D. Kostic et al.   GASTROENTEROLOGY

Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma

(2014) Sarah E. Kerr et al.   HUMAN PATHOLOGY

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

(2014) Chris J. Weston et al.   JOURNAL OF CLINICAL INVESTIGATION

The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II

(2014) Noortje G. Rossen et al.   Journal of Crohns & Colitis

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Changes in Gastric and Lung Microflora With Acid Suppression

(2014) Rachel Rosen et al.   JAMA Pediatrics

Characterization of the bile and gall bladder microbiota of healthy pigs

(2014) Esther Jiménez et al.   MicrobiologyOpen

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

(2013) J. H. Tabibian et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study

(2013) Tao Wu et al.   BMC GENOMICS

Primary Sclerosing Cholangitis and Cholangiocarcinoma: Pathogenesis and Modes of Diagnostics

(2013) Hanno Ehlken et al.   DIGESTIVE DISEASES

Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis

(2013) Raynoo Thanan et al.   FREE RADICAL BIOLOGY AND MEDICINE

Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management

(2013) John E. Eaton et al.   GASTROENTEROLOGY

Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma

(2013) Massimiliano Cadamuro et al.   HEPATOLOGY

Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis

(2013) Janosch Katt et al.   HEPATOLOGY

Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma

(2013) Margriet R. Timmer et al.   INFLAMMATORY BOWEL DISEASES

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

(2013) Genta Kakiyama et al.   JOURNAL OF HEPATOLOGY

Primary sclerosing cholangitis

(2013) Gideon M Hirschfield et al.   LANCET

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

(2013) Koji Atarashi et al.   NATURE

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

(2013) Jimmy Z Liu et al.   NATURE GENETICS

Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience

(2012) W. Kwon et al.   INFECTION

Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

(2012) David N. Abarbanel et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

(2012) Kirsten Boonstra et al.   JOURNAL OF HEPATOLOGY

Human gut microbiome viewed across age and geography

(2012) Tanya Yatsunenko et al.   NATURE

The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations

(2012) Anthony A. Fodor et al.   PLoS One

Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation

(2011) Natalie Steck et al.   GASTROENTEROLOGY

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives

(2011) M. Joossens et al.   GUT

Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis

(2011) Natalie A. Molodecky et al.   HEPATOLOGY

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut

(2011) Ekihiro Seki et al.   JOURNAL OF PHYSIOLOGY-LONDON

Enterotypes of the human gut microbiome

(2011) Manimozhiyan Arumugam et al.   NATURE

Microbial Dysbiosis in Colorectal Cancer (CRC) Patients

(2011) Iradj Sobhani et al.   PLoS One

Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells

(2011) I. M. Toller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies

(2010) Ulrich Beuers et al.   HEPATOLOGY

Bezafibrate for the treatment of primary sclerosing cholangitis

(2010) Suguru Mizuno et al.   JOURNAL OF GASTROENTEROLOGY

Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state

(2010) Geoffrey Gonzalez-Escobedo et al.   NATURE REVIEWS MICROBIOLOGY

Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage

(2010) R. W. Crawford et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

p-ANCAs in autoimmune liver disorders recognise human  -tubulin isotype 5 and cross-react with microbial protein FtsZ

(2009) B. Terjung et al.   GUT

Diagnosis and management of primary sclerosing cholangitis

(2009) Roger Chapman et al.   HEPATOLOGY

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

(2009) Keith D. Lindor et al.   HEPATOLOGY

Liver cirrhosis caused by Exophiala dermatitidis

(2009) K. H. Hong et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis

(2009) E. Oztas et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Occult hepatitis B virus infection in patients with autoimmune liver diseases

(2009) Sarah P. Georgiadou et al.   LIVER INTERNATIONAL

Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study

(2008) Marina G Silveira et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Identification of a Bile-Induced Exopolysaccharide Required for Salmonella Biofilm Formation on Gallstone Surfaces

(2008) R. W. Crawford et al.   INFECTION AND IMMUNITY

A core gut microbiome in obese and lean twins

(2008) Peter J. Turnbaugh et al.   NATURE

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA